These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12546968)

  • 1. Chemoproteomics as a basis for post-genomic drug discovery.
    Beroza P; Villar HO; Wick MM; Martin GR
    Drug Discov Today; 2002 Aug; 7(15):807-14. PubMed ID: 12546968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leadlikeness and structural diversity of synthetic screening libraries.
    Verheij HJ
    Mol Divers; 2006 Aug; 10(3):377-88. PubMed ID: 17031539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases.
    Ghose AK; Viswanadhan VN; Wendoloski JJ
    J Comb Chem; 1999 Jan; 1(1):55-68. PubMed ID: 10746014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemistry challenges in lead optimization: silicon isosteres in drug discovery.
    Showell GA; Mills JS
    Drug Discov Today; 2003 Jun; 8(12):551-6. PubMed ID: 12821303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug discovery: the leading edge.
    Chapman T
    Nature; 2004 Jul; 430(6995):109-15. PubMed ID: 15229608
    [No Abstract]   [Full Text] [Related]  

  • 6. Rendezvous in chemical space? Comparing the small molecule compound libraries of Bayer and Schering.
    Schamberger J; Grimm M; Steinmeyer A; Hillisch A
    Drug Discov Today; 2011 Jul; 16(13-14):636-41. PubMed ID: 21554978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of lead discovery strategies on the properties of drug candidates.
    Keserü GM; Makara GM
    Nat Rev Drug Discov; 2009 Mar; 8(3):203-12. PubMed ID: 19247303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compound scale-up at the discovery-development interface.
    Nikitenko AA
    Curr Opin Drug Discov Devel; 2006 Nov; 9(6):729-40. PubMed ID: 17117683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LASSOO: a generalized directed diversity approach to the design and enrichment of chemical libraries.
    Koehler RT; Dixon SL; Villar HO
    J Med Chem; 1999 Nov; 42(22):4695-704. PubMed ID: 10579831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Metabolite-likeness' as a criterion in the design and selection of pharmaceutical drug libraries.
    Dobson PD; Patel Y; Kell DB
    Drug Discov Today; 2009 Jan; 14(1-2):31-40. PubMed ID: 19049901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From genes to products: innovations in drug discovery.
    Afshar M
    Drug Discov Today; 2003 May; 8(9):392-4. PubMed ID: 12706655
    [No Abstract]   [Full Text] [Related]  

  • 12. Advances and Progress in Drug Design - SMi's ninth annual meeting.
    Welchman R
    IDrugs; 2010 Apr; 13(4):239-42. PubMed ID: 20373252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three decades of structure- and property-based molecular design.
    Müller K
    Chimia (Aarau); 2014; 68(7-8):472-82. PubMed ID: 25437386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large compound databases for structure-activity relationships studies in drug discovery.
    Scior T; Bernard P; Medina-Franco JL; Maggiora GM
    Mini Rev Med Chem; 2007 Aug; 7(8):851-60. PubMed ID: 17692047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoproteomic-enabled phenotypic screening.
    Conway LP; Li W; Parker CG
    Cell Chem Biol; 2021 Mar; 28(3):371-393. PubMed ID: 33577749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive survey of chemical libraries for drug discovery and chemical biology: 2006.
    Dolle RE; Le Bourdonnec B; Goodman AJ; Morales GA; Salvino JM; Zhang W
    J Comb Chem; 2007; 9(6):855-902. PubMed ID: 17877417
    [No Abstract]   [Full Text] [Related]  

  • 17. BioCores: identification of a drug/natural product-based privileged structural motif for small-molecule lead discovery.
    Kombarov R; Altieri A; Genis D; Kirpichenok M; Kochubey V; Rakitina N; Titarenko Z
    Mol Divers; 2010 Feb; 14(1):193-200. PubMed ID: 19468851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug discovery in the kinase inhibitory field using the Nested Chemical Library technology.
    Kéri G; Székelyhidi Z; Bánhegyi P; Varga Z; Hegymegi-Barakonyi B; Szántai-Kis C; Hafenbradl D; Klebl B; Muller G; Ullrich A; Erös D; Horváth Z; Greff Z; Marosfalvi J; Pató J; Szabadkai I; Szilágyi I; Szegedi Z; Varga I; Wáczek F; Orfi L
    Assay Drug Dev Technol; 2005 Oct; 3(5):543-51. PubMed ID: 16305311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Charting, navigating, and populating natural product chemical space for drug discovery.
    Lachance H; Wetzel S; Kumar K; Waldmann H
    J Med Chem; 2012 Jul; 55(13):5989-6001. PubMed ID: 22537178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of chemistry for the future of the pharma industry.
    Wild H; Heimbach D; Huwe C
    Angew Chem Int Ed Engl; 2011 Aug; 50(33):7452-3. PubMed ID: 21818828
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.